Genomic Profiling

QIAGEN announced the early access launch of QIAsymphony Connect, its next-generation automated nucleic acid purification platform at AMP 2025, with full release expected in mid-2026. The new platform features enhanced speed, traceability, and connectivity for liquid biopsy applications. QIAGEN also showcased Sample to Insight workflows for comprehensive genomic profiling via a partnership with Element Biosciences and highlighted HRD assay development in collaboration with Myriad Genetics Inc., solidifying its focus on precision oncology.